Spectral Medical (TSE:EDT) Shares Up 2% – What’s Next?

Spectral Medical Inc. (TSE:EDT – Get Free Report)’s share price rose 2% during trading on Monday. The stock traded as high as C$1.07 and last traded at C$1.02. 64,450 shares were traded during trading, an increase of 22% from the average session volume of 52,794 shares. The stock had previously closed at C$1.00.

Spectral Medical Price Performance

The business has a 50 day moving average price of C$1.10 and a two-hundred day moving average price of C$1.30. The stock has a market cap of C$299.43 million, a PE ratio of -34.00 and a beta of 0.86. The company has a debt-to-equity ratio of 26.03, a quick ratio of 0.45 and a current ratio of 0.61.

Spectral Medical (TSE:EDT – Get Free Report) last released its earnings results on Friday, November 6th. The company reported C($0.01) earnings per share (EPS) for the quarter. The firm had revenue of C$0.28 million during the quarter. Research analysts expect that Spectral Medical Inc. will post -0.05 earnings per share for the current fiscal year.

About Spectral Medical

(Get Free Report)

Spectral is a Phase 3 company seeking U.S. FDA approval for its unique product for the treatment of patients with septic shock, Toraymyxin¿ (‘PMX’). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s FDA cleared Endotoxin Activity Assay (EAA¿), the clinically available test for endotoxin in blood. PMX is approved for therapeutic use in Japan and Europe, licensed by Health Canada, and has been used safely and effectively with over 360,000 units sold worldwide to date.

Recommended Stories

Receive News & Ratings for Spectral Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Medical and related companies with MarketBeat.com's FREE daily email newsletter.